Back to search

Ireland· IE-PA-PA0711/289/003

Sunitinib Rowex 50 mg hard capsules

A sunitinib product containing sunitinib, registered in Ireland by Rowex Limited,. The same ATC class is registered in 2 of our 19 countries.

ATC L01XE04

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedSunitinib Rowex 50 mg hard capsulesATCL01XE04REGISTER NO.IE-PA-PA0711/289/003PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Sunitinib is registered in 2 of 19 countries.

Countries holding a registration under ATC L01XE04 (sunitinib), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 1 of them publish a price we can compare per daily dose

Sunitinib · ATC L01XE04

2 / 19 countries

  • Ireland
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Sunitinib
Manufacturer
Rowex Limited,
Country
Ireland (IE)
ATC code
L01XE04
ATC class
Sunitinib
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0711/289/003

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

509 interactions on record for sunitinib.

Graded by severity as the source publishes them — 99 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Sunitinib · interactions on record

509 records

  • 99 severe
  • 362 moderate
  • 3 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • QuinidineC01BA01severe

45 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sunitinib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sunitinib products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Sunitinib Bluefish, Sunitinib G.L.
  • Belgium · Sunitinib Sandoz, Sunitinib Teva
  • Bulgaria · Суганет, Сунитиниб Алкалоид-Инт
  • Cyprus · Sunitinib Msn, Sunitinib Sapiens
  • Czechia · Sunitinib Pharmagen, Sunitinib Sandoz
  • Germany · Sunitinib Al, Sunitinib Aqvida
  • Denmark · Sunitinib Medical Valley, Sunitinib Sandoz
  • Estonia · Sunitinib Sandoz, Sunitinib Teva
  • Spain · Sunitinib Bluepharma Indústria, Sunitinib Dr. Reddys
  • Finland · Sunitinib Ratiopharm, Sunitinib Sandoz
  • France · Sunitinib Arrow, Sunitinib Biogaran
  • United Kingdom (Northern Ireland) · Sunitinib Amarox, Sunitinib Dr. Reddy’s
  • Greece · Egotux, Sunidem
  • Croatia · Sunitinib Alkaloid-Int, Sunitinib Be Pharma
  • Hungary · Klertis, Suganet
  • Iceland · Sunitinib Accord, Sunitinib Demo
  • Italy · Sunitinib Aurobindo, Sunitinib Dr. Reddy’s
  • Liechtenstein · Sunitinib Accord, Sutent
  • Lithuania · Klertis, Sunitinib G.L. Pharma
  • Luxembourg · Sunitinib Eg, Sunitinib Teva
  • Latvia · Sunitinib Be Pharma, Sunitinib G.L. Pharma
  • Malta · Sunitinib Dr. Reddy’s, Sunitinib Medichem
  • Netherlands · Egotux, Klertis
  • Norway · Sunitinib Accord, Sunitinib Medical Valley
  • Poland · Klertis, Sunitinib Bluefish
  • Portugal · Sunitinib Bluepharma, Sunitinib Bluepharma Indústria
  • Romania · Klertis, Sunitinib Alkaloid-Int
  • Sweden · Sunitinib Bluefish, Sunitinib Eugia
  • Slovenia · Sunitinib Alkaloid-Int, Sunitinib Msn
  • Slovakia · Klertis, Sunitinib G.L. Pharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eb2b6718-42dc-4c7c-90c2-f532e37784ce
GET /v1/drugs/eb2b6718-42dc-4c7c-90c2-f532e37784ce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "L01XE",
    "L01XE04"
  ],
  "strength": null,
  "pa_number": "PA0711/289/003",
  "substances": [
    "Sunitinib"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "03/05/2019",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": "IC0147-023-001"
}

See everything about sunitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.